Korea skimping on research spending

Published: 2013-10-31 06:59:00

Updated: 2013-10-31 06:59:00

Despite its grand plan to nurture 12 globally competitive pharmaceutical companies by 2020, the government spend considerably less on research and development (R&D) of 43 innovative drug firms, industry data showed recently.

According to the Korea Health Industry Development Institute (KHIDI) data submitted to Rep. Nam Soon In-soon of the Democratic Party, the ministry’s combined R&D spendi...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.